Assembly Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $240.6M | $59.4M |
| FY2021 | — | $168.9M | $45.6M |
| FY2022 | — | $82.7M | $52.4M |
| FY2023 | — | $41.1M | $19.8M |
| FY2024 | — | $33.4M | $38.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $240.6M | $59.4M |
| FY2021 | — | $168.9M | $45.6M |
| FY2022 | — | $82.7M | $52.4M |
| FY2023 | — | $41.1M | $19.8M |
| FY2024 | — | $33.4M | $38.3M |